Based on a SCOPUS search conducted in late January 2011, looking for the top 15 highly cited MSK Publications, the following reference was cited 53 times and is ranked in fifth place. View the journal or search for the specific reference at the journal’s home page by clicking on the journal title below. For additional information about cited reference searching, contact Reference Services.

• Poulikakos PI, Zhang C, Bollag G, Shokat KM, Rosen N. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. Nature. 2010;464(7287):427-430.

Based on a SCOPUS search conducted in late January 2011, looking for the top 15 highly cited MSK Publications, the following reference was cited 52 times and is ranked in sixth place. View the journal or search for the specific reference at the journal’s home page by clicking on the journal title below. For additional information about cited reference searching, contact Reference Services.

• Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat, CV, Perl AE, Rabinowitz JD, Carroll M, Su SM, Sharp KA, Levine, RL, Thompson CB.  The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate. Cancer Cell. 2010;17(3):225-234.

Based on a SCOPUS search conducted in late January 2011, looking for the top 15 highly cited MSK Publications, the following reference was  cited 42 times and is ranked in seventh place. View the journal or search for the specific reference at the journal’s home page by clicking on the journal title below. For additional information about cited reference searching, contact Reference Services.

• Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh I-T, Ravdin P, Bugarini R, Baehner FL, Davidson NE, Sledge GW, Winer EP, Hudis C, Ingle JN, Perez EA, Pritchard KI, Shepherd L, Gralow JR, Yoshizawa C, Allred DC, Osborne CK, Hayes DF.  Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. The Lancet Oncology. 2010;11(1):55-65.